Category Pharmaceuticals and Biotech
Press Release
Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses
Oxidative stress drives aging and is a key factor in diseases like Alzheimer's, Age-related Macular Degeneration (AMD), cardiovascular diseases, cancer, and diabetes. It also plays a critical role in the progression of viral infections, such as avian influenza (bird flu), by exacerbating inflammation and cellular damage. Directly addressing oxidative stress and its consequences is essential to treating the underlying causes of these conditions and mitigating the severity of viral outbreaks. Read More
Press Release
Zepbound Coupons and Discounts From Duty Free Meds
Duty Free Meds is proud to introduce a new Zepbound coupon offering to help lower patient costs associated with the weight-loss medication. These coupons can help customers spend less on weight-loss drugs and other medications. Read More
Press Release
PillSafe Founders' Interview Featured on Bloomberg, Fox Business, and Nasdaq
The interview with Dr. John Barr and Jim Patton tackles medication safety and how PillSafe Technologies secures prescriptions, prevents abuse, and protects patients and doctors, leading the fight against the opioid crisis. Read More
Press Release
Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price
Transaction follows a $5 million non-dilutive credit line from the same trusted partner, further reinforcing Telomir's financial strength and growth potential. Read More
Press Release
Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1
Building on preclinical success demonstrating age reversal, longevity, and increased healthspan, Telomir-1 appears to address insulin resistance at its root, achieving reversal to near pre-diabetic levels Read More
Press Release